321
Views
36
CrossRef citations to date
0
Altmetric
Research Articles

High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database

, , , , , , , , , & show all
Pages 1113-1116 | Received 25 May 2011, Accepted 07 Nov 2011, Published online: 03 Feb 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Junshik Hong, Ji Hyun Kim, Kyoung Hwa Lee, Hee Kyung Ahn, Sanghui Park, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Dong Bok Shin & Jae Hoon Lee. (2014) Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:10, pages 2312-2318.
Read now
Martin Hutchings & Aaron Polliack. (2012) When and how to perform surveillance imaging in patients with lymphoma, and is it worth it?. Leukemia & Lymphoma 53:6, pages 1015-1016.
Read now

Articles from other publishers (33)

Ping Wang, Kaige Chen, Jiayang Wang, Zihao Ni, Naijian Shang & Wei Meng. (2023) A new nomogram for assessing complete response (CR) in gastric diffuse large B-cell lymphoma (DLBCL) patients after chemotherapy. Journal of Cancer Research and Clinical Oncology 149:12, pages 9757-9765.
Crossref
Ora Paltiel, Galor Raviv Sharabi, Reut Tzemach, Talya Rechavi, Estherina Trachtenberg, Neta Goldschmidt, Eldad J Dann & Rachel Bar-Shalom. (2021) Limiting surveillance imaging for patients with lymphoma in remission: a mixed methods study leading to a Choosing Wisely recommendation. BMJ Quality & Safety 30:4, pages 300-310.
Crossref
Urshila Durani, Dennis Asante, Herbert C. Heien, Carrie A. Thompson, Thorvardur Halfdanarson, Lindsey Sangaralingham, Prema Peethambaram, Fernando J. Quevedo, Jose C. Villasboas & Ronald S. Go. (2020) Changes in Frequency of Surveillance Imaging of Survivors of Diffuse Large B-Cell Lymphoma After the American Society of Hematology Choosing Wisely Recommendations. JCO Oncology Practice, pages OP.20.00362.
Crossref
Takanori Fukuta, Noriko Nishimura, Yuko Shirouchi, Norihito Inoue, Hideki Uryu, Yoshiharu Kusano, Yuko Mishima, Masahiro Yokoyama, Naoko Tsuyama, Kengo Takeuchi & Yasuhito Terui. (2020) Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study. International Journal of Hematology 111:4, pages 567-573.
Crossref
David M. Kurtz. (2019) Prognostication with circulating tumor DNA: is it ready for prime time?. Hematology 2019:1, pages 47-52.
Crossref
Koung Jin Suh, Ki Hwan Kim, Ryul Kim, Ja Min Byun, Miso Kim, Jin Hyun Park, Bhumsuk Keam, Tae Min Kim, Jin-Soo Kim, In Sil Choi & Dae Seog Heo. (2019) Costs and clinical outcomes of patients with diffuse large B-cell lymphoma in first remission: role of PET/CT surveillance. The Korean Journal of Internal Medicine 34:4, pages 894-901.
Crossref
Ghulam Rehman Mohyuddin, Ashley Elizabeth Clark, John Roller, Leyla Shune, Tara Lin, Neil Dunavin, Ajoy Dias, Siddhartha Ganguly, Sunil Abhyankar, Joseph McGuirk & Anurag Singh. (2018) Utility of routine surveillance imaging for diffuse large B-cell lymphoma post autologous transplant: A single center experience. Hematology/Oncology and Stem Cell Therapy 11:3, pages 135-141.
Crossref
Christopher Melani, Wyndham H. Wilson & Mark Roschewski. (2018) Monitoring clinical outcomes in aggressive B-cell lymphoma: From imaging studies to circulating tumor DNA. Best Practice & Research Clinical Haematology 31:3, pages 285-292.
Crossref
A.M. García Vicente, M.P. Talavera Rubio, E. Dominguez Ferreras, C. Calle Primo, M. Amo-Salas, M.J. Tello Galán, G.A. Jimèc)nez Londoño, F. Jimèc)nez Aragón, B. Hernández Ruiz & Á. Soriano Castrejón. (2018) 18 F-FDG PET/contrast enhanced CT in the standard follow-up of patients with lymphoma. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 37:3, pages 151-155.
Crossref
A.M. García Vicente, M.P. Talavera Rubio, E. Dominguez Ferreras, C. Calle Primo, M. Amo-Salas, M.J. Tello Galán, G.A. Jiménez Londoño, F. Jiménez Aragón, B. Hernández Ruiz & Á. Soriano Castrejón. (2018) 18 F-FDG PET/TC con contraste intravenoso en el seguimiento estandarizado de pacientes con linfoma. Revista Española de Medicina Nuclear e Imagen Molecular 37:3, pages 151-155.
Crossref
Matthew C. Cheung, Nicole Mittmann, Craig C. Earle, Farah Rahman, Ning Liu & Simron Singh. (2018) Are We Choosing Wisely in Lymphoma? Excessive Use of Surveillance CT Imaging in Patients With Diffuse Large B-cell Lymphoma (DLBCL) in Long-term Remission. Clinical Lymphoma Myeloma and Leukemia 18:1, pages e27-e34.
Crossref
Susan M. Hiniker & Richard T. Hoppe. (2017) Post-treatment surveillance imaging in lymphoma. Seminars in Oncology 44:5, pages 310-322.
Crossref
Jonathon B. Cohen, Madhusmita Behera, Carrie A. Thompson & Christopher R. Flowers. (2017) Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma. Blood 129:5, pages 561-564.
Crossref
Tycel Phillips & Jessica Mercer. (2017) Surveillance Scans in Lymphoma: Friend or Foe?. Current Treatment Options in Oncology 18:2.
Crossref
Narendranath Epperla, Namrata Shah, Mehdi Hamadani, Kristin Richardson, Jonathan T. Kapke, Asmita Patel, Sravanthi P. Teegavarapu, George Carrum, Parameswaran N. Hari, Sai R. Pingali, Reem Karmali & Timothy S. Fenske. (2016) Impact of Routine Surveillance Imaging on Outcomes of Patients With Diffuse Large B-Cell Lymphoma After Autologous Hematopoietic Cell Transplantation. Clinical Lymphoma Myeloma and Leukemia 16:12, pages 672-678.
Crossref
Tarec Christoffer El-GalalyLasse Hjort JakobsenMartin HutchingsPeter de Nully BrownHerman Nilsson-EhleElisabeth SzékelyKaren Juul MylamViktoria HjalmarHans Erik JohnsenMartin BøgstedMats Jerkeman. (2015) Routine Imaging for Diffuse Large B-Cell Lymphoma in First Complete Remission Does Not Improve Post-Treatment Survival: A Danish–Swedish Population-Based Study. Journal of Clinical Oncology 33:34, pages 3993-3998.
Crossref
Martin Hutchings & Sally Barrington. (2015) FDG-PET for the early treatment monitoring, for final response and follow-up evaluation in lymphoma. Clinical and Translational Imaging 3:4, pages 271-281.
Crossref
Jonathon B Cohen, David M Kurtz, Ashley D Staton & Christopher R Flowers. (2015) Next-generation surveillance strategies for patients with lymphoma. Future Oncology 11:13, pages 1977-1991.
Crossref
David M. Kurtz, Michael R. Green, Scott V. Bratman, Florian SchererChih Long LiuChristian A. KunderKazuhiro TakahashiCynthia GloverColm KeaneShingo KihiraBrendan VisserJason CallahanKatherine A. KongMalek FahamKaren S. CorbelliDavid MiklosRanjana H. AdvaniRonald LevyRodney J. HicksMark HertzbergRobert S. OhgamiMaher K. GandhiMaximilian Diehn & Ash A. Alizadeh. (2015) Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing. Blood 125:24, pages 3679-3687.
Crossref
Gregory A. Abel. (2015) Does Surveillance Imaging After Treatment for Diffuse Large B-Cell Lymphoma Really Work?. Journal of Clinical Oncology 33:13, pages 1427-1429.
Crossref
Scott F. HuntingtonJakub SvobodaJalpa A. Doshi. (2015) Cost-Effectiveness Analysis of Routine Surveillance Imaging of Patients With Diffuse Large B-Cell Lymphoma in First Remission. Journal of Clinical Oncology 33:13, pages 1467-1474.
Crossref
Susan M. Hiniker, Erqi L. Pollom, Michael S. Khodadoust, Margaret M. Kozak, Guofan Xu, Andrew Quon, Ranjana H. Advani & Richard T. Hoppe. (2015) Value of Surveillance Studies for Patients With Stage I to II Diffuse Large B-Cell Lymphoma in the Rituximab Era. International Journal of Radiation Oncology*Biology*Physics 92:1, pages 99-106.
Crossref
Jonathon B. Cohen & Christopher R. Flowers. (2014) Optimal disease surveillance strategies in non-Hodgkin lymphoma. Hematology 2014:1, pages 481-487.
Crossref
Carrie A. ThompsonHerve GhesquieresMatthew J. MaurerJames R. CerhanPierre BironStephen M. AnsellCatherine Chassagne-ClémentDavid J. InwardsThérèse GargiPatrick B. JohnstonEmmanuelle Nicolas-VirelizierWilliam R. MaconMarie PeixIvana N. MicallefCatherine SebbanGrzegorz S. NowakowskiLuis F. PorrataGeorge J. WeinerThomas E. WitzigThomas M. HabermannBrian K. Link. (2014) Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma. Journal of Clinical Oncology 32:31, pages 3506-3512.
Crossref
TC El-Galaly, Karen Juul Mylam, Martin Bøgsted, Peter Brown, Maria Rossing, Anne Ortved Gang, Anne Haglund, Bente Arboe, Michael Roost Clausen, Paw Jensen, Michael Pedersen, Anne Bukh, Bo Amdi Jensen, Christian Bjørn Poulsen, Francesco d'Amore & Martin Hutchings. (2014) Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma. American Journal of Hematology 89:6, pages 575-580.
Crossref
Ryan C. LynchAndrew D. ZelenetzJames O. ArmitageKenneth R. Carson. (2014) Surveillance Imaging for Lymphoma: Pros and Cons. American Society of Clinical Oncology Educational Book:34, pages e388-e395.
Crossref
Ofir Wolach, Hanna Bernstine, Yonatan Edel, Osnat Bairey, Ofer Shpilberg, David Groshar & Meir Lahav. (2014) Limited Positron Emission Tomography-Computed Tomography for Restaging of Lymphoma: A Strategy for Reducing Radiation Exposure among Patients with Early-Stage Curable Lymphoma. Acta Haematologica 131:4, pages 239-244.
Crossref
É. Herin, J. Chalaye, J.-L. Lagrange, K. Belhadj, É. De Kerviler, A. Luciani, A. Rahmouni & E. Itti. 2014. Imagerie Post-Thérapeutique en Oncologie. Imagerie Post-Thérapeutique en Oncologie 265 298 .
Mark J. Roschewski & Wyndham H. Wilson. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 2033 2059.e8 .
Kamal Patel, Nira Hadar, Jounghee Lee, Barry A. Siegel, Bruce E. Hillner & Joseph Lau. (2013) The Lack of Evidence for PET or PET/CT Surveillance of Patients with Treated Lymphoma, Colorectal Cancer, and Head and Neck Cancer: A Systematic Review. Journal of Nuclear Medicine 54:9, pages 1518-1527.
Crossref
C Y Cheah, M S Hofman, M Dickinson, A Wirth, D Westerman, S J Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, H M Prince, D A Carney, D S Ritchie, R J Hicks & J F Seymour. (2013) Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy. British Journal of Cancer 109:2, pages 312-317.
Crossref
Oguz Akin, Sandra B. Brennan, D. David Dershaw, Michelle S. Ginsberg, Marc J. Gollub, Heiko Schöder, David M. Panicek & Hedvig Hricak. (2012) Advances in oncologic imaging. CA: A Cancer Journal for Clinicians 62:6, pages 364-393.
Crossref
Tung-Liang Lin, Ming-Chung Kuo, Lee-Yung Shih, Po Dunn, Po-Nan Wang, Jin-Hou Wu, Tzung-Chih Tang, Hung Chang, Yu-Shin Hung & Shu-Chen Lu. (2012) Value of surveillance computed tomography in the follow-up of diffuse large B-cell and follicular lymphomas. Annals of Hematology 91:11, pages 1741-1745.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.